Merck & Co., Inc. is 34.3x more valuable than CYTOKINETICS INC by market capitalization ($294.13 B vs $8.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CYTK | MRK |
|---|---|---|
| Market cap | $8.58 B | $294.13 B |
| US-listed rank | #1034 | #44 |
| Revenue (latest FY) | $88.04M | $65.01B |
| Net income (latest FY) | -$784.96M | $18.25B |
| Net margin | -891.6% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 2,450 | 996 |
Merck & Co., Inc. is 34.3x more valuable than CYTOKINETICS INC by market capitalization ($294.13 B vs $8.58 B).
In their latest fiscal years, CYTOKINETICS INC reported $88.04M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: CYTOKINETICS INC and Merck & Co., Inc., or browse the full rankings.